|
⚲
|
| Keyboard |
| During Matthew
✚
|
|
|---|---|
| CIK # | 0001704631 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001704631] | |
| 4 | [0001704631] | |
| SC 13G | [0001704631] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| During Matthew | OVID Therapeutics Inc | [2019-02-14] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| During Matthew | |
| Ovid Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Ovid Therapeutics Inc OVID
Stock Option (Right to Buy) · derivative
|
2019-04-01 | Grant | 75,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
|
2019-02-24 | Grant | 70,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Employee Stock Option (Right to Buy) · derivative
|
2018-01-19 | Grant | 110,000 | $0.00 | |
|
Ovid Therapeutics Inc OVID
Common Stock
|
2017-05-10 | Conversion | 28,245 | ||
|
Ovid Therapeutics Inc OVID
Series A Preferred Stock · derivative
|
2017-05-10 | Conversion | 28,245 | $0.00 |